CC BY-NC-ND 4.0 · Laryngorhinootologie 2018; 97(S 02): S167
DOI: 10.1055/s-0038-1640290
Poster
Otologie: Otology

Genotype-phenotype correlation in hereditary hearing loss

S Dofek
1   Universitäts-HNO-Klinik, Tübingen
,
P Gamerdinger
1   Universitäts-HNO-Klinik, Tübingen
,
S Fehr
2   Praxis für Humangentik, Tübingen
,
S Biskup
2   Praxis für Humangentik, Tübingen
,
M Müller
1   Universitäts-HNO-Klinik, Tübingen
,
H Löwenheim
1   Universitäts-HNO-Klinik, Tübingen
,
A Tropitzsch
1   Universitäts-HNO-Klinik, Tübingen
› Author Affiliations
 

Mutations in 66 genes are known for autosomal recessive, in 36 genes for autosomal dominant and in 5 genes with x-linked non-syndromic types of hearing loss. Furthermore, there are known digenic mechanisms in hereditery hearing loss.

284 patients were selected for a retrospective analysis and we performed genetic diagnostics by panel diagnostic.

In more than 80% of the patients genetic mutations in hearing loss genes were detected, in 54% the diagnosis was secure or most likely to cause hereditary hearing loss. The most frequent genes were GJB2 (17%), MYO7A (8%), MYO15A (7%), TECTA (6%) and MYO6 (3%). The autosomal recessive forms of GJB2 (DFNB1A) and MYO7A (DFNB2) were associated with pre-lingual deafness. Patients with mutations in MYO15A (DFNB3) showed a variable beginning and progressive character of hearing loss. The clinical progress of the autosomal dominant forms in MYO7A (DFNA11), TECTA (DFNA8/DFNA12) and MYO6 (DFNA22) showed a later on-set of hearing impairment and manifestation of the deafness. CI-patients with GJB2-mutation showed the best hearing results (80% at 65dB). The speech perception of patients with mutations in MYO15A, TECTA und MYO6 was 70%, in patients with MYO7A-mutations 40%. Patients with mutated CACNAD1, MYO7A, LOXHD1, PTPRQ, CDH23, TFAP2A, COL9A3, TMPRSS3, GPR98 and TJP2 showed speech perception scores below 50%.

High throughput sequencing allows to diagnose known deafness genes. Genotype-phenotype-correlation allows predictions regarding the clinical course of hearing impairment. The treatment with a CI shows a good outcome for the most common genes GJB2, MYO15A, TECTA and MYO6.



Publication History

Publication Date:
18 April 2018 (online)

© 2018. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Stuttgart · New York